Synthes GmbH
L'entreprise Synthes GmbH a actuellement 547 offres d'emploi en ligne.
L'entreprise Synthes GmbH a actuellement 547 offres d'emploi en ligne.
Synthes GmbH , Columbia
New
Synthes GmbH , Johnson
New
Synthes GmbH , Johnson
New
Synthes GmbH , Johnson
New
Synthes GmbH , Abo
New
Synthes GmbH , FLORIDA
New
Synthes GmbH , Baroda
New
Synthes GmbH , Johnson
New
Synthes GmbH , Johnson
New
Synthes GmbH , Johannesburg
New
Synthes GmbH , Cork
New
Synthes GmbH , Johnson
New
Johnson & Johnson is recruiting for Clinical Account Specialist 1 for Biosense Webster, Inc. located in Augusta, GA and Columbia, SC.
At Johnson & Johnson,?we believe health is everything. Our strength in healthcare innovation empowers us to build a?world where complex diseases are prevented, treated, and cured,?where treatments are smarter and less invasive, and?solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/.
For more than 130 years, diversity, equity & inclusion (DEI) has been a part of our cultural fabric at Johnson & Johnson and woven into how we do business every day. Rooted in Our Credo, the values of DEI fuel our pursuit to create a healthier, more equitable world. Our diverse workforce and culture of belonging accelerate innovation to solve the world’s most pressing healthcare challenges.
We know that the success of our business – and our ability to deliver meaningful solutions – depends on how well we understand and meet the diverse needs of the communities we serve. Which is why we foster a culture of inclusion and belonging where all perspectives, abilities and experiences are valued and our people can reach their potential.
At Johnson & Johnson, we all belong.
Atrial fibrillation (AFIB) is a quivering or irregular heartbeat (arrhythmia) that can lead to blood clots,?stroke, heart failure and other heart-related complications. 20 million people around the world suffer from AFIB each year. Biosense Webster, Inc. is the global leader in the science of diagnosing and treating heart rhythm disorders. The company established its leadership in electrophysiology with the development of the first real-time, 3D cardiac mapping and navigation technology, as well as the first electrophysiology catheter. The introduction of the company’s CARTO® 3 System in 2009 revolutionized 3D mapping technology by increasing the accuracy, speed, and efficiency of the cardiac ablation procedure.
As the Clinical Account Specialist, you will: